Thus, the modulation of CD68 expression in accordance with the reduction of cell proliferation measured within the tumor confirms the ability of TRAM-34 to reduce glioma invasiveness since the overexpression of CD68, recently found in several types of cancer, has been correlated with tumor aggressiveness and malignant progression (Zhang et al., 2022). This evidence concerns the gene CD68 and neoplasm.